Great Point Partners LLC Ocular Therapeutix, Inc Transaction History

Great Point Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.85 - $10.93 $3.96 Million - $11.2 Million	1,028,723 Added 146.96%	1,728,723 $15.7 Million
Q4 2023 Feb 14, 2024	BUY	$2.08 - $4.52 $1.46 Million - $3.16 Million	700,000 New	700,000 $3.12 Million
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $8.92 Million - $13.2 Million	-919,887 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.43 - $19.16 $1.17 Million - $1.67 Million	-87,125 Reduced 8.65%	919,887 $13 Million
Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $2.39 Million - $3.34 Million	150,850 Added 17.62%	1,007,012 $16.5 Million
Q4 2020 Feb 16, 2021	BUY	$7.91 - $22.95 $6.77 Million - $19.6 Million	856,162 New	856,162 $17.7 Million

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.